sub:assertion {
  drugbank:DB00656 a biolink:Drug ;
    rdfs:label "Trazodone" ;
    biolink:category biolink:Drug .
  mondo:0013600 a biolink:Disease ;
    rdfs:label "insomnia (disease)" ;
    biolink:category biolink:Disease .
  sub:association rdf:object mondo:0013600 ;
    rdf:predicate biolink:treats ;
    rdf:subject drugbank:DB00656 ;
    a biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
    rdfs:label """The most common off-label uses were for manic-depressive psychosis treated with citalopram and primary insomnia treated with trazodone. Several patient and clinician characteristics were positively associated with off-label prescribing, including seeing a psychiatrist (OR: 1.06, 95% CI, 1.01–1.12; p = 0.03) instead of another type of clinician, the office visit taking place in the Western region of the country (OR: 1.09, 95% CI, 1.01–1.17; p = 0.02), and the patient having 3 or more chronic conditions (OR: 1.12, 95% CI, 1.02–1.14;
p = 0.003).""" ;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory ;
    biolink:category biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
    biolink:has_population_context sub:context ;
    biolink:publications pmid:30024873 ;
    biolink:relation ncit:C94303 .
  sub:context a biolink:Cohort ;
    rdfs:label "adults" ;
    biolink:category biolink:Cohort .
}